Longpre Lara 4
4 · Mirum Pharmaceuticals, Inc. · Filed Feb 5, 2024
Insider Transaction Report
Form 4
Longpre Lara
Chief Development Officer
Transactions
- Sale
Common Stock
2024-02-02$26.19/sh−847$22,184→ 104,407 total
Footnotes (1)
- [F1]Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units.